Cargando…

Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers

BACKGROUND: Evidence is accumulating that a cannabis withdrawal syndrome is common, of clinical significance, and has a clear time course. Up till now, very limited data exist on the cannabis withdrawal symptoms in patients with co-morbid substance use disorders, other than cannabis use and tobacco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hesse, Morten, Thylstrup, Birgitte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015312/ https://www.ncbi.nlm.nih.gov/pubmed/24118963 http://dx.doi.org/10.1186/1471-244X-13-258

Ejemplares similares

Inter-rater agreement of comorbid DSM-IV personality disorders in substance abusers
por: Hesse, Morten, et al.
Publicado: (2008)

Substance abusers' personality disorders and staff members' emotional reactions
por: Thylstrup, Birgitte, et al.
Publicado: (2008)

Did you get any help? A post-hoc secondary analysis of a randomized controlled trial of psychoeducation for patients with antisocial personality disorder in outpatient substance abuse treatment programs
por: Thylstrup, Birgitte, et al.
Publicado: (2017)

Psycho-education for substance use and antisocial personality disorder: a randomized trial
por: Thylstrup, Birgitte, et al.
Publicado: (2015)

Impulsive Lifestyle Counselling versus treatment as usual to reduce offending in people with co-occurring antisocial personality disorder and substance use disorder: a post hoc analysis
por: Hesse, Morten, et al.
Publicado: (2022)

Assessment of personality-related levels of functioning: a pilot study of clinical assessment of the DSM-5 level of personality functioning based on a semi-structured interview
por: Thylstrup, Birgitte, et al.
Publicado: (2016)

Group versus individual treatment for substance use disorders: a study protocol for the COMDAT trial
por: Karsberg, Sidsel Helena, et al.
Publicado: (2021)

Safety and tolerability of sauna detoxification for the protracted withdrawal symptoms of substance abuse
por: Lennox, Richard D, et al.
Publicado: (2018)

Commentary on Chai et al: Drug use, self‐harm, suicide, and use of registry data in epidemiological research
por: Hesse, Morten, et al.
Publicado: (2022)

One opioid user saving another: the first study of an opioid overdose-reversal and naloxone distribution program addressing hard-to-reach drug scenes in Denmark
por: Thylstrup, Birgitte, et al.
Publicado: (2019)

Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings
por: Kesner, Andrew J., et al.
Publicado: (2021)

Cannabis and Psychosis Through the Lens of DSM-5
por: Pearson, Nathan T., et al.
Publicado: (2019)

Suicide among people treated for drug use disorders: a Danish national record-linkage study
por: Hesse, Morten, et al.
Publicado: (2020)

The Readiness Ruler as a measure of readiness to change poly-drug use in drug abusers
por: Hesse, Morten
Publicado: (2006)

Standardised assessment of personality – a study of validity and reliability in substance abusers
por: Hesse, Morten, et al.
Publicado: (2008)

Beyond the high: Mapping patterns of use and motives for use of cannabis as medicine
por: Kvamme, Sinikka L., et al.
Publicado: (2021)

Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample
por: Kvamme, Sinikka L., et al.
Publicado: (2021)

Personality disorders in substance abusers: Validation of the DIP-Q through principal components factor analysis and canonical correlation analysis
por: Hesse, Morten
Publicado: (2005)

ILC-OPI: impulsive lifestyle counselling versus cognitive behavioral therapy to improve retention of patients with opioid use disorders and externalizing behavior: study protocol for a multicenter, randomized, controlled, superiority trial
por: Hesse, Morten, et al.
Publicado: (2021)

The co-morbidity of DSM-V Gambling with DSM-V mental disorders and substance abuse in a Kenyan context of high risk schizophrenia
por: Ndetei, David M., et al.
Publicado: (2023)

Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
por: Nyhlén, Anna, et al.
Publicado: (2011)

Prevalence of pulmonary disease in alcohol and poly substance abuse
por: Sheikh, Ghazanfar
Publicado: (2021)

The impact of the COVID-19 lockdown on services for substance use in Denmark: Implications for meeting users’ needs and recommendations for the future
por: del Palacio-Gonzalez, Adriana, et al.
Publicado: (2022)

Clinical management of cannabis withdrawal
por: Connor, Jason P., et al.
Publicado: (2022)

Validity of self-reported criminal justice system involvement in substance abusing women at five-year follow-up
por: Jansson, Irene, et al.
Publicado: (2008)

An epidemiological snapshot of cannabis use and comorbid substance abuse, depression and anxiety in young Romanians
por: Ionescu, T. C., et al.
Publicado: (2023)

Quantifying the Clinical Significance of Cannabis Withdrawal
por: Allsop, David J., et al.
Publicado: (2012)

The cannabis withdrawal syndrome: current insights
por: Bonnet, Udo, et al.
Publicado: (2017)

The Puzzling Unidimensionality of DSM-5 Substance Use Disorder Diagnoses
por: MacCoun, Robert J.
Publicado: (2013)

Tobacco and cannabis poly-substance and poly-product use trajectories across adolescence and young adulthood
por: Lanza, H. Isabella, et al.
Publicado: (2021)

The impact of poly-traumatization on treatment outcomes in young people with substance use disorders
por: Karsberg, Sidsel, et al.
Publicado: (2021)

Examining the relation of personality factors to substance use disorder by explanatory item response modeling of DSM-5 symptoms
por: Chen, Fu, et al.
Publicado: (2019)

Substance abuse co-morbidity in schizophrenia: An inpatient study of course and outcome
por: Aich, Tapas K., et al.
Publicado: (2005)

Psychiatric Morbidity of Cannabis Abuse
por: Sarkar, Jaydip, et al.
Publicado: (2003)

Psychotic Cannabis Withdrawal: A Clinical Case
por: Ramos, Berta, et al.
Publicado: (2022)

Disorders Related to Use of Psychoactive Substances in DSM-5: Changes and Challenges
por: Bhad, Roshan, et al.
Publicado: (2015)

What should be done with antisocial personality disorder in the new edition of the diagnostic and statistical manual of mental disorders (DSM-V)?
por: Hesse, Morten
Publicado: (2010)

Association patterns of cannabis abuse and dependence with risk of problematic non-substance-related dysregulated and addictive behaviors
por: Perales, José C., et al.
Publicado: (2021)

Early 5‐HT (6) receptor blockade prevents symptom onset in a model of adolescent cannabis abuse
por: Berthoux, Coralie, et al.
Publicado: (2020)

Early 5‐HT(6) receptor blockade prevents symptom onset in a model of adolescent cannabis abuse
por: Berthoux, Coralie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u264lbv28ubbq8ni6llum5tdve